Schwab's SCHD Undercuts Fidelity's FDVV on Cost and Yield in Dividend ETF Race
A direct comparison of two of the largest U.S. dividend ETFs shows Schwab's defensive fund delivering a higher yield at less than half the cost of Fidelity's tech-heavy rival, sharpening the trade-off income investors face between stability and growth exposure.
Schwab's U.S. Dividend Equity ETF (SCHD) is paying investors a 3.1% trailing yield while charging just 0.06% in annual fees, undercutting Fidelity's High Dividend ETF (FDVV) on both measures. The Fidelity fund yields 2.7% and costs 0.15%, more than double Schwab's expense ratio. For the roughly $34.43 a share SCHD trades at, that translates into $1.05 per share distributed over the past 12 months, versus $1.73 on FDVV's roughly $64.33 price.
The gap matters because dividend ETFs are among the most widely held vehicles in retail and advisory portfolios, and even small differences in fee drag compound over years. A 0.09-percentage-point cost advantage, paired with a 0.36-point yield edge, gives SCHD a structural head start for investors whose primary goal is income.
Diverging sector bets
The two funds, however, are not simply competing on price. They are built on fundamentally different philosophies. SCHD, launched in 2011, tracks a disciplined index of 103 stocks weighted toward defensive sectors: healthcare at 21%, consumer staples at 20%, and energy at 15%. Its largest single positions are Abbott Laboratories at 4.78%, Amgen at 4.63%, and Merck at 4.42%.
FDVV, which debuted in 2016, holds 119 stocks with a pronounced tilt toward growth. Technology accounts for 29% of the portfolio, financial services 19%, and consumer cyclicals 13%. Nvidia is the top holding at 7.18%, followed by Apple at 5.94% and Microsoft at 5.09%. That concentration captures more upside in bull markets but carries a measurably higher beta, meaning the fund's price swings are wider relative to the S&P 500.
What the trade-off means for allocators
For portfolio managers and financial advisers, the choice between the two funds is less about which is "better" in the abstract and more about which risk profile suits the mandate. SCHD behaves closer to a bond-proxy equity sleeve, smoothing volatility in mixed markets. FDVV functions more like a growth fund that happens to pay a dividend, and its performance will track the fortunes of mega-cap technology far more tightly.
Investors who bought FDVV expecting a straightforward income product may find themselves with significant single-stock technology risk. Conversely, those holding SCHD should recognise that the fund's defensive construction will likely lag in sustained tech rallies.
The cost question persists
Fee-sensitive institutional buyers will note that SCHD's 0.06% expense ratio places it among the cheapest actively screened equity ETFs on the market. FDVV's 0.15% is still low by historical standards but is harder to justify if the investor's objective is pure yield rather than capital appreciation.
Neither fund carries unusual structural quirks, and both distribute quarterly. The decision, ultimately, rests on whether an investor is paying for income stability or for a dividend wrapper around a growth portfolio. The numbers increasingly suggest those are two distinct products, not close substitutes.
